{"x402Version":2,"network":"base-mainnet","asset":"USDC","accuracy":"https://api.biotechcatalystsentinel.com/v1/accuracy","resources":[{"method":"GET","path":"/v1/catalysts/upcoming","price":"$0.02","accepts":["base","solana"],"url":"https://api.biotechcatalystsentinel.com/v1/catalysts/upcoming","description":"Upcoming FDA PDUFA decision dates for US-listed biotechs, extracted from primary SEC 8-K/6-K filings. Date accuracy is independently backtested (median 1-day error) — verify free at GET /v1/accuracy before paying.","input_example":{"within_days":90,"limit":200},"output_example":{"data":[{"drug_name":"ONS-5010/LYTENAVA (bevacizumab-vikg)","company":"Outlook Therapeutics, Inc.","ticker":"OTLK","indication":"wet AMD","pdufa_date":"2026-07-29","stage":"set","confidence":"high","source_url":"https://www.sec.gov/Archives/edgar/data/1649989/..."}],"meta":{"total":1}}}]}